Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: NGAML
Next-Generation Sequencing, Acute Myeloid Leukemia, 11-Gene Panel, Varies
Fees 
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
- Authorized users can sign in to Test Prices for detailed fee information.
- Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
- Prospective clients should contact their Regional Manager. For assistance, contact Customer Service.
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
CPT codes are provided by the performing laboratory.
81450
LOINC® Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| NGAML | Next Gen Sequencing, AML, 11 Gene | In Process |
| Result ID | Test Result Name | Result LOINC ValueApplies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure. |
|---|---|---|
| MP038 | Specimen Type | 31208-2 |
| 43554 | NGAML Result | No LOINC Needed |
| 43488 | Pathogenic Mutations Detected | 82939-0 |
| 43487 | Interpretation | 69047-9 |
| 43489 | Clinical Trials | 82786-5 |
| 43490 | Variants of Unknown Significance | 93367-1 |
| 43491 | Additional Notes | 48767-8 |
| 43492 | Method Summary | 85069-3 |
| 43493 | Disclaimer | 62364-5 |
| 43494 | AML Panel Gene List | 36908-2 |
| 43495 | Reviewed By | 19139-5 |